We are live on ! Find out more
MCM

MontVue Capital Management Portfolio holdings

AUM $174M
1-Year Est. Return 24.95%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+24.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
+$866K
Cap. Flow
+$1.41M
Cap. Flow %
1.08%
Top 10 Hldgs %
69.74%
Holding
61
New
6
Increased
8
Reduced
17
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 1.54%
2 Financials 1.3%
3 Communication Services 0.77%
4 Energy 0.57%
5 Consumer Staples 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
51
Visa
V
$671B
$237K 0.18%
+751
New +$226K
PG icon
52
Procter & Gamble
PG
$339B
$228K 0.17%
+1,357
New +$231K
AMZN icon
53
Amazon
AMZN
$2.98T
$221K 0.17%
+1,007
New +$206K
HES
54
DELISTED
Hess
HES
$213K 0.16%
1,599
TSM icon
55
TSMC
TSM
$2.19T
$208K 0.16%
+1,055
New +$204K
IEMG icon
56
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$208K 0.16%
3,980
COF icon
57
Capital One
COF
$134B
$206K 0.16%
+1,157
New +$200K
VTV icon
58
Vanguard Morningstar Value ETF
VTV
$192B
$202K 0.15%
1,194
BOTJ icon
59
Bank Of The James
BOTJ
$123M
$202K 0.15%
12,727
CMCSA icon
60
Comcast
CMCSA
$89B
-5,123
Closed -$214K
NVO
61
Novo Nordisk
NVO
$208B
-2,089
Closed -$249K

Similar funds

MontVue Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, MontVue Capital Management held 61 positions worth $131M, up 0.66% from $130M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

MontVue Capital Management's Q4 2024 filing shows 6 new, 8 increased, 17 reduced and 2 closed positions. Its largest new stake was Goldman Sachs: 483 shares worth $277K. The largest sale was Novo Nordisk, an estimated $249K.

By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 1.3% a quarter earlier, followed by Financials and Communication Services.

  • MontVue Capital Management's largest Q4 2024 buy was Goldman Sachs: 483 shares worth $277K.
  • MontVue Capital Management added most to iShares Core S&P Total US Stock Market ETF in Q4 2024, an estimated $678K increase.
  • MontVue Capital Management's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $177K.
  • MontVue Capital Management fully exited Novo Nordisk in Q4 2024, selling an estimated $249K.
  • MontVue Capital Management's ten largest holdings make up 70% of its $131M portfolio in Q4 2024.
  • MontVue Capital Management opened 6 new positions and closed 2 in Q4 2024.
  • MontVue Capital Management's portfolio value rose 0.66% quarter-over-quarter to $131M.

Based on MontVue Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.